Pronounced Anti-Leukemia Activity in Vivo of the Novel Peptidic CXCR4 Antagonist LY2510924 As a Single Agent and in Combination with Chemotherapy

B. Cho,Z. Zeng,H. Mu,Zhiqiang Wang,T. McQueen,Marina Protopopova,J. Cortes,J. Marszalek,Sheng-Bin Peng,R. Davis,D. Thornton,M. Andreeff,M. Konopleva

Published 2014 in Blood

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2014
Venue
Blood
Publication date
2014-12-06
Fields of study
Medicine
Identifiers
DOI 10.1182/BLOOD.V124.21.3745.3745
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

No references are available for this paper.

CITED BY

Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies
2024cites this paper